Objective: To evaluate over a 7-year follow-up period the relationships between changes in body composition, fat distribution and pulmonary function in a sample of elderly men and women. Design: Longitudinal clinical study. Subjects: A total of 47 women and 30 men aged 71.6±2.3 and 71.7±2.2 years, respectively, at baseline with body mass index (BMI) values of 24.96 ± 3.28 and 27.04 ± 3.35 kg m À2 were followed for 7 years. Measurements: Body weight, waist circumference, sagittal abdominal diameter (SAD), fat-free mass (FFM) and fat mass as measured by dual energy X-ray absorptiometry (DXA) and forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) by spirometry were evaluated at baseline and after a 7-year mean follow-up. Results: In women as in men there were no significant changes in weight, SAD and BMI. A significant decrease in height and FFM was observed in both women and men. Height-adjusted FEV1 and FVC decreased significantly in women and men over the 7-year follow-up. Changes in SAD were the most powerful predictors of 7-year follow-up of FEV1 and FVC after taking into account, respectively, baseline FEV1 and FVC. Linear regression analysis, performed by using 7-year follow-up lung function variables as dependent variables and changes in body composition variables as independent variables, showed that 1 cm SAD increase predicted a decrease in FEV1 and FVC of 31 and 46 ml, respectively, and 1 kg FFM decrease predicted a decrease in FVC of 38 ml. After subdividing our study population into four categories of change in FFM and SAD, patients with decreased FFM and increased SAD showed the highest probability of having a worsening in FEV1 and FVC. Conclusion: Increase in abdominal fat and FFM decline are significant predictors of lung function decline in the elderly. Old subjects developing both abdominal fat gain and FFM loss show the highest probability of developing worsening in lung function.
Introduction
Both cross-sectional and longitudinal studies have shown age-dependent body composition changes, with increases in fat mass especially visceral fat and decreases in muscle mass in both men and women. [1] [2] [3] [4] [5] [6] It is well known that lung function also deteriorates with aging. 7 Impaired pulmonary function is clinically relevant as it is associated with increased morbidity and mortality rates. [8] [9] [10] Several factors may contribute to age-dependent decline of lung function.
A few cross-sectional studies have considered the relationship between body composition variables, indices of body fat distribution and lung function in the elderly. [11] [12] [13] [14] These studies demonstrate, especially in men, that the amount of fat-free mass (FFM) positively influences respiratory function, whereas centrally distributed fat deposits have a negative effect on lung function. 12, 13 No longitudinal studies have so far been undertaken to determine if age-dependent body composition changes are related to lung function impairment in elderly subjects.
The aim of the current study was to evaluate over a 7-year follow-up period the relationships between body composition changes and lung function in a sample of elderly men and women who were free from chronic obstructive pulmonary disease (COPD) at baseline.
Methods

Subjects
Clinical status, body composition and pulmonary tests were evaluated at baseline in 202 Caucasians, 92 men and 110 women aged, respectively, 71.7±2.2 and 71.6±2.3 years, with a body mass index (BMI) of 27.2 ± 3.4 and 26.4 ± 4.4 kg m
À2
. Men and women were eligible to take part in the study, if they could walk 0.8 km (0.5 min) without difficulty and were free of cognitive impairment on the basis of a Mini-Mental State Examination score 424. None of the subjects engaged in physical exercise more than once a week during the study; walking or slow cycling were the usual physical activities performed. Exclusion criteria included renal insufficiency, disabling knee osteoarthritis, heart failure (New York Heart Association class 2 or higher) or COPD (as defined by clinical records). Individuals who had lost more than 5% of their body weight in the year preceding the study were also excluded. All the subjects involved in the study were retired and completely independent at the Activities of Daily Living scale at baseline evaluation.
A total of 27 participants (13.36%) were excluded from the follow-up study for presence at baseline of COPD defined by clinical records or as quantified by the baseline spirometric tests with ratios of forced expiratory volume in 1 s to forced vital capacity (FEV1:FVC) o69%.
7 During the 7-year follow- No significant difference was observed for any of the variables considered between men who were excluded (n ¼ 58) and those included in the present analysis.
All participants gave their informed consent and the experimental protocol was approved by the Ethical Committee of our University.
Anthropometry
With the subjects wearing light indoor clothes and no shoes, body weight was measured to the nearest 0.1 kg on a scale (Salus, Milan, Italy) and height to the nearest 0.5 cm with a stadiometer (Salus). BMI was then calculated as body weight adjusted for stature. Circumferences were measured to the nearest 0.5 cm with the use of a 1-cm-wide metal measuring tape while subjects were standing. WC was measured as the minimum abdominal circumference between the xyphoid process and the umbilicus. Hip circumference was measured as the maximum circumference over the buttocks. The waistto-hip ratio (WHR) was calculated as the ratio between these two circumferences.
SAD was measured with a portable, sliding beam, abdominal caliper while the subjects were in a supine position. SAD was measured as the largest supine anteroposterior diameter between the xyphoid process and the umbilicus. 15 The subjects were asked to inhale and exhale gently and the arm of the caliper was brought down to touch the abdominal wall without compression. All subjects were examined in a flat standard hospital bed.
Body composition
Total body fat mass (FM) and total FFM were determined using DXA. Baseline body composition evaluation was performed using a Hologic QDR 2000 fan beam densitometer with software version 7.2. Due to technical reasons the 7-year body composition evaluation was performed using a Hologic QDR 4500 fan beam densitometer with software version 8.21. The characteristics and physical concepts of DXA measurements have been described elsewhere. 16 All metal objects (jewellery, snaps and belts) were removed. Measurements were taken with the subject positioned supine on the scanning ).
Dietary intake
A trained dietician performed a 24-h dietary recall in order to assess the dietary habits of each subject enrolled in the study. The record data were then processed by the dietician using special software to calculate daily intake of energy, protein, fat, carbohydrate and alcohol based on the tables furnished by the Italian National Institute of Nutrition.
22
Smoking status Current cigarette smokers were defined as participants who smoked cigarettes daily or who had stopped smoking o5 years before the date of baseline spirometry. Former smokers were defined as participants who had smoked cigarettes daily and had stopped smoking X5 years before the date of baseline spirometry. Nonsmokers were participants who had smoked o5-10 packs of cigarettes during their lifetime.
Health status
The presence of chronic conditions was determined using standardized questionnaires previously used in the Italian Longitudinal Study on Aging. 23 Chronic conditions assessed included cardiovascular disease, lung disease (emphysema, chronic bronchitis, asthma and others), degenerative joint disease and hypertension. A total of 12 women showed a geriatric depression scale score suggestive of mild depression: however none of these subjects was eligible for medical treatment for depression after careful clinical evaluation.
Biochemical measures
Venous blood samples for hemoglobin and albumin levels were obtained after overnight fasting. Albumin was determined using a colorimetric test (Vitros 950 ALB slides; J&J Health, Cone Systems, Piscataway, NJ, USA); the color complex formed was measured by reflectance spectrophotometry. The sensitivity of this assay has been shown to be 10 g l
À1
; intraassay coefficient of variations (CVs) were 1.3-1.5%.
Statistical methods
Results are presented as means ± s.d. Changes in each body composition and anthropometric variables, as well as hemoglobin, albumin and lung function between baseline and 7-year follow-up were calculated as absolute change (7-year follow-up minus baseline value). All variables were considered as normally distributed according to the Kolmogorov-Smirnov test (data not shown). Differences in mean changes between baseline and 7-year follow-up in anthropometric variables, body composition and respiratory function were tested separately in men and women using a paired t-test, even after subdividing the study sample in weight gainers and weight losers by using, respectively, positive and negative body weight changes to categorize them.
Pearson and partial correlation analyses were used to test association between variables. Linear regression equations with lung function variables (FEV1 or FVC) at 7-year followup being the dependent variable and lung function at baseline (FEV1 or FVC), change in body composition variables, sex, smoking status, and change in albumin levels being the independent variables were fitted. Decline in height-adjusted FEV1 and FVC from baseline to 7-year follow-up was used as categories: stable or losers using a cutoff at the 50th percentile of the corresponding change.
Categories of change in FFM and SAD were also considered. FFM categories were coded using two levels with a cutoff given by the 50th percentile of the corresponding change (3.55 kg FFM loss for men and 0.9 kg for women) respectively defined decreased and stable FFM categories. When considering SAD categories, positive or negative SAD change was used to code two categories, respectively, defined increased and decreased SAD categories.
On the basis of the combination of FFM and SAD categories, subjects were further classified into four groups: a decreased FFM/increased SAD group (n ¼ 18), a stable FFM/ decreased SAD group (n ¼ 15), a stable FFM/increased SAD group (n ¼ 21) and a decreased FFM/decreased SAD group (n ¼ 23). Observed percentages of subjects with worsening in FEV1 and FVC according to FFM and SAD status were then calculated.
A significance level of 0.05 was used throughout the study. All statistical analyses were performed using the SPSS statistical package (version 12.0 for Window). 24 Results Tables 1 and 2 show the main characteristics of the study population (mean±s.d.) at baseline and at the 7-year followup, respectively, in women and men. A total of 47 women and 30 men with mean baseline ages of 71. , respectively, were included in the study. Among the women 14.9% were current smokers, 68.1% never smoked cigarettes and 17% were Aging, pulmonary function and body composition A Rossi et al former smokers; of the men 16.7% were current smokers, 33.3% never smoked cigarettes and 50% were former smokers.
In women there were no significant changes in weight, SAD and BMI, whereas there were significant increases in waist (Po0.001) and WHR (Po0.05). In men, weight, SAD, waist and BMI did not change significantly. A significant decrease in height was observed in both women and men (Po0.01). In women and in men total FM did not change significantly, whereas total FFM (both Po0.01) significantly decreased. A significant decline in albumin levels in men as in women was observed over the 7-year follow-up (Po0.01). Energy, alcohol (Tables 1 and 2 ) and macronutrient (data not shown in table) intake did not change significantly over the 7-year follow-up period in men as in women.
The study population was then split into two weight change categories: weight losers and weight gainers. A total of 44.7% of women and 63.3% of men lost weight during the follow-up period. In weight-losing men BMI (Po0.001), WC (P ¼ 0.005), SAD (Po0.05), FM (P ¼ 0.001) and FFM Decreases in lung function were observed in both sexes and for all the considered spirometric indexes. Heightadjusted FEV1 and FVC were significantly decreased in women and men over the 7-year follow-up (Po0.001).
FEV1 at 7-year follow-up was strongly correlated with FEV1 at baseline as well as all the other considered variables (Table 3) . After having taken into account the effect of FEV1 at baseline, the variable showing the highest correlation (in absolute value) with FEV1 at 7-year follow-up was the variation in SAD. After having taken into account the effect of both FEV1 at baseline and change in SAD none of the other considered variables remained significantly correlated with FEV1 at 7-year follow-up.
A linear regression equation with FEV1 at 7-year follow-up being the dependent variable and FEV1 at baseline, change in SAD, sex, smoking status, and change in albumin levels being the independent variables was fitted. This model explained about 87% of the variance of FEV1 at 7-year follow-up. Holding FEV1 constant at baseline (as well as sex, smoking status and change in albumin levels), for an increase of 1 cm in SAD the model predicted a decrease in FEV1 of about 31 ml (95% confidence interval, CI: 15-46 ml; data not shown in table).
FVC at 7-year follow-up was strongly correlated with FVC at baseline as well as all the other considered variables (Table 4) . After having taken into account the effect of FVC at baseline, the variable showing the highest correlation (in absolute value) with FVC at 7-year follow-up was the variation in SAD. After having taken into account the effect of both FVC at baseline and change in SAD, only the variation in FFM remained, among the considered variables, significantly correlated with FVC at 7-year follow-up.
A linear regression equation with FVC at 7-year follow-up being the dependent variable and FVC at baseline, change in SAD and FFM, sex, smoking status, and change in albumin levels being the independent variables was fitted. This model explained about 87% of the variance of FVC at 7-year followup. Holding FVC constant at baseline and change in FFM as well as sex, smoking status, and change in albumin levels, for an increase of 1 cm in SAD the model predicted a decrease in FVC of about 46 ml (95% C.: 25-67 ml). On the other hand, holding FVC constant at baseline and change in SAD as well as sex, smoking status, and change in albumin levels, for a decrease of 1 kg in FFM the model predicted a decrease in FVC of about 38 ml (95% CI: 17-60 ml; data not shown in table).
In order to better understand the relation between simultaneous body composition changes in SAD and FFM Measured by dual-energy X-ray absorptiometry. Aging, pulmonary function and body composition A Rossi et al and pulmonary function changes we subdivided our study population in four categories of change in FFM and SAD. The probability of having a worsening in FEV1 was (almost) the same for subjects with stable FFM and increased SAD (observed: 11 out of 21; 52.4%) and for subjects with decreased FFM and increased SAD (observed: 12 out of 23; 52.2%). Patients with decreased FFM and increased SAD showed the highest probability of having a worsening in FEV1 (observed: 12 out of 15; 80.0%), whereas patients with stable FFM and decreased SAD (observed: 4 out of 18; 22.2%) showed the lowest probability of having a worsening in FEV1. Similar findings were obtained considering the probability of having a worsening in FVC: 57.1% for subjects with stable FFM and increased SAD (observed: 12 out of 21) and 52.2% for subjects with decreased FFM and stable SAD (observed: 12 out of 23). Patients with decreased FFM and increased SAD showed the highest probability of having a worsening in FVC (observed: 10 out of 15; 66.6%), whereas patients with stable FFM and decreased SAD (observed: 5 out of 18; 27.8%) showed the lowest probability of having a worsening in FVC (data not shown in table).
Discussion
Our study clearly shows that FFM decrease and SAD increase across aging are associated with pulmonary function decline in the elderly; our study also shows that increases in abdominal fat, after adjusting for baseline lung function, sex, smoking status and change in albumin levels, are the most significant predictors of lung function decline in the elderly and that elderly subjects who simultaneously lose FFM and gain abdominal fat, show the highest probability of developing worsening in lung function.
In both men and women, over a 7-year follow-up, we observed a decline in all spirometric variables. Heightstandardized FVC and FEV1 decreased, respectively, 25 and 31 ml per year in men, 23 and 28 ml per year in women. These findings are in line with those of Burr et al., 25 who observed a decline in FEV1 and FVC with age, independent of smoking or environmental exposure, in 400 subjects aged 70 years or older. However, to the best of our knowledge this is the first study to demonstrate association between changes over time in body composition and decreased pulmonary function in the elderly. In our subjects, both FFM decrease and SAD increase were associated with a deterioration of lung function. Our findings that SAD, a surrogate marker of visceral fat, is negatively associated with a worsening of lung function complement and expand previous reports 12, 13 as observed over a 7-year follow-up study in old men and women with wide range of BMI. It has been shown at least in obese subjects that the amount of abdominal fat is inversely associated with chest wall compliance. [26] [27] [28] A consistent negative association between WC and pulmonary function has recently been demonstrated in normal weight, overweight and obese subjects, suggesting that FM stored in the abdominal cavity, particularly visceral fat, most likely directly impedes the descent of the diaphragm leading to primarily restrictive respiration impairment. 28 Among obese subjects, there is evidence of peripheral airway obstruction, as manifested by air trapping and reduced maximum expiratory flow rates. 29, 30 Thus, independent of smoking status, excess FM in the abdomen may contribute to airflow limitation. Crosssectional studies of elderly patients have already shown that lung function decreases with increasing fat mass and central body fat distribution. 12, 13 As total adiposity and particularly visceral fat tend to increase with aging 3, 31, 32 our data may provide evidence of a link between age-related body fat redistribution and the decline in lung function observed in the elderly. In our subjects the probability of having a worsening in FVC was independently significantly associated to the decline in FFM even after adjusting for baseline FVC and SAD changes. It has been previously shown that the amount of FFM is related to lung function. 33 In patients with COPD and low body weight (o80% of normal body weight), a significant association between respiratory muscle strength and FFM as measured by DXA has been observed. 34 An association between respiratory muscle strength and ventilatory function was previously reported among older subjects. 12, 35 Moreover, our data support a link between ageassociated worsening in lung function and age-associated FFM decline. On the other hand, it is well known that a decrease of the quantity as well as of the strength of diaphragm, inspiratory and expiratory intercostals muscles occurs with age, 36 producing a progressive decrease in lung function as measured by spirometry.
Our data seem also to show that old subjects with abdominal fat gain and FFM loss prove the highest probability of developing worsening in lung function.
These results, obtained by combining SAD and FFM modifications, suggest that age-related changes in body composition (that is, central body fat redistribution and FFM loss) may have additive negative effects on pulmonary function. Thus, our findings seem to be in line with previous observations that a combination of FFM loss and fat gain with aging, recently called 'sarcopenic obesity', 37 is more strongly associated with disability than either body composition type alone. 32, 38, 39 Some limitations of our study should be mentioned. First, for technical reasons we needed to move from DXA Hologic 2000 (used at baseline examination) to the DXA Hologic 4500. The Hologic 4500 has been previously shown to overestimate FFM with respect to the Hologic 2000. 17, 18 To correct this bias we used a regression equation performing two evaluations of body composition in 13 of our subjects using the 2 different instruments and adjusted values of body composition variables were used for the 7-year followup. 19 The use of adjusted values, instead of measured values Aging, pulmonary function and body composition A Rossi et al of body composition variables, could have induced an important bias. Second, our study population was small and limited to healthy old men and women initially well functioning and in good health, and thus cannot be considered representative of a normal aging population.
Third, because of the small number of subjects enrolled in the present longitudinal study we did not exclude smokers from our analysis. Thus, it is not possible to rule out the hypothesis that smoking itself could be responsible of the worsening of pulmonary function observed in our study population over the 7-year follow-up. However, our findings showing that the association between body composition changes and pulmonary function were still significant even after adjusting for smoking status are in line with previous observations. 13, 40 Then, the occurrence of a selection bias due to the high number of dropout in our study sample could not be ruled out at least in women. In fact women who dropped showed at baseline lower height-adjusted FEV1 and FVC values, were older and presented higher values of BMI, FM and SAD and thus could have greater pulmonary function loss over a 7-year follow-up period.
It is not possible to exclude intermediate fluctuations in body composition variables as well as in lung function due to the low proportion of repeated measures. Actually, it is important to note that lung function decline observed in our subjects seem to be in line with previous observations, thus suggesting that our findings reflect lung aging.
Finally, we did not measure visceral fat, but rather surrogates such as waist and SAD. However, we have previously shown SAD to be a reliable index of visceral fat. 15 It is indeed possible that the determination of visceral fat in the abdomen and in the chest may have lead to even more significant results. In conclusion our 7-year longitudinal study shows that FFM decrease and SAD increase across aging are associated with pulmonary function decline in the elderly and that elderly subjects who simultaneously lose FFM and gain abdominal fat, show the highest probability of developing worsening in lung function.
